MDM2 and benign prostatic hyperplasia: In case of BPH-1 and CAFTD cells, we can rule out an effect of epitope masking by phosphorylation [33], as MDM2 protein can be detected by several phosphorylation-insensitive monoclonal antibodies (Supplementary Figure S1C–S1D).